Comparison of Inhaled Ciclesonide (640 mcg/Day) and Fluticasone Propionate (1000 mcg/Day) in Patients With Moderate and Severe Persistent Asthma
Phase of Trial: Phase III
Latest Information Update: 05 Dec 2016
At a glance
- Drugs Ciclesonide; Fluticasone propionate
- Indications Asthma
- Focus Adverse reactions
- Sponsors ALTANA Pharma; AstraZeneca
- 04 May 2012 Company (Takeda Global Research and Development Center) added as reported by ClinicalTrials.gov.
- 27 Oct 2006 Status change
- 26 Nov 2005 New trial record.